Register Login

RAPT Therapeutics Inc (RAPT)

(10% Negative) RAPT Therapeutics Inc (RAPT) Announces Delay in opportunity Trials for ozureprubart Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 7:02 p.m.

    📋 RAPT Therapeutics Inc (RAPT) - Clinical Trial Update

    Filing Date: 2026-01-14

    Accepted: 2026-01-14 08:00:31

    Event Type: Clinical Trial Update

    Event Details:

    RAPT Therapeutics Inc (RAPT) Announces Clinical Trial Update RAPT Therapeutics Inc (RAPT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: opportunity, inherent
    • Diseases/Conditions: ozureprubart
    • Clinical Stage: clinical trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: THE SCIENCE TO OVERCOME INFLAMMATION

    🔬 Clinical Development Pipeline (RAPT Therapeutics Inc):

    Product Type Development Stage Therapeutic Area Source
    RPT904 DRUG Phase PHASE2 Ig-E Mediated Food Allergy ClinicalTrials.gov
    RAP-219 DRUG Phase PHASE2 Focal Epilepsy ClinicalTrials.gov
    VRP-encapsulated saRNA encoding IL-12 (3 x 10^8 viral particles per injection) BIOLOGICAL Phase PHASE1 Head and Neck Cancers- Squamous Cell ClinicalTrials.gov
    Pembrolizumab (KEYTRUDA®) DRUG Phase PHASE1 Head and Neck Cancers- Squamous Cell ClinicalTrials.gov
    VRP-encapsulated saRNA encoding IL-12 (1 x 10^9 viral particles per injection) BIOLOGICAL Phase PHASE1 Head and Neck Cancers- Squamous Cell ClinicalTrials.gov
    [Ac 225]RTX-2358 DRUG Phase PHASE1 Advanced Soft Tissue Sarcoma ClinicalTrials.gov
    Placebo OTHER Phase PHASE2 Ig-E Mediated Food Allergy ClinicalTrials.gov
    FLX925 DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    RPT193 DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Ipilimumab DRUG Phase PHASE2 Advanced Melanoma ClinicalTrials.gov
    FLX475 DRUG Phase PHASE2 Advanced Melanoma ClinicalTrials.gov
    14C RPT193 DRUG Phase PHASE1 Healthy Male Subjects ClinicalTrials.gov
    PTI-122 DRUG Phase EARLY_PHASE1 Prostate Cancer ClinicalTrials.gov
    PSMA-Targeted [In-111]-Labeled Trillium Compound DRUG Phase EARLY_PHASE1 Prostate Cancer ClinicalTrials.gov
    Arm 2B: TRACT/MONO CNI BIOLOGICAL Phase PHASE2 Kidney Transplantation ClinicalTrials.gov
    Arm 2A: TRACT/MONO mTOR BIOLOGICAL Phase PHASE2 Kidney Transplantation ClinicalTrials.gov
    Arm 1: SOC (mTOR + CNI) DRUG Phase PHASE2 Kidney Transplantation ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: RAPT Therapeutics Inc
    • Ticker Symbol: RAPT

Search

News categories